Victoza Approved for Treatment of Type 2 Diabetes in China


The Chinese State Food and Drug Administration (SFDA) has approved Victoza for the treatment of type 2 diabetes.

Diabetes is a rapidly growing disease in China, and Victoza offers a unique treatment option by effectively reducing HbA1c and weight with a low risk of hypoglycemia in people with type 2 diabetes inadequately controlled by oral anti-diabetic agents.

Novo Nordisk expects to launch Victoza in China in the second half of 2011.

Leave a Reply

Notify of
Copyright © 2009-2018 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.